Stock EKTA B ELEKTA AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Elekta AB

Equities

EKTA B

SE0000163628

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:34 2024-04-26 am EDT 		5-day change 1st Jan Change
75.6 SEK +2.30% Intraday chart for Elekta AB +1.54% -8.16%
Apr. 22 Elekta, GE HealthCare Team Up for New Cancer Treatment Planning Services MT
Apr. 22 Elekta and MIM Software Inc. Announce Collaboration to Combine Best-Of-Breed Solutions for Advanced Treatment Planning in the Delivery of Radiation Therapy CI

Valuation

Fiscal Period: Abril 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 42,978 34,533 43,290 25,500 32,882 28,885 - -
Enterprise Value (EV) 1 43,417 36,165 44,064 27,032 35,324 31,906 31,512 30,941
P/E ratio 35.8 x 31.8 x 34.5 x 22.1 x 34.8 x 19.5 x 15.8 x 14.1 x
Yield 1.6% 1.99% 1.94% 3.6% 2.79% 3.33% 3.76% 3.93%
Capitalization / Revenue 3.17 x 2.37 x 3.15 x 1.75 x 1.95 x 1.59 x 1.5 x 1.41 x
EV / Revenue 3.2 x 2.48 x 3.2 x 1.86 x 2.09 x 1.75 x 1.64 x 1.51 x
EV / EBITDA 16.5 x 12.3 x 14.2 x 10.1 x 13.6 x 9.36 x 8.13 x 7.44 x
EV / FCF 45.1 x 144 x 25.8 x 60.1 x 101 x 35.5 x 21.4 x 17.1 x
FCF Yield 2.22% 0.7% 3.87% 1.66% 0.99% 2.82% 4.68% 5.85%
Price to Book 5.53 x 4.26 x 5.28 x 2.86 x 3.38 x 2.82 x 2.58 x 2.37 x
Nbr of stocks (in thousands) 382,027 382,083 382,083 382,083 382,083 382,083 - -
Reference price 2 112.5 90.38 113.3 66.74 86.06 75.60 75.60 75.60
Announcement Date 5/29/19 5/29/20 5/28/21 5/25/22 5/25/23 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 13,555 14,601 13,763 14,548 16,869 18,224 19,230 20,435
EBITDA 1 2,639 2,931 3,110 2,682 2,596 3,410 3,876 4,159
EBIT 1 1,696 1,657 1,906 1,643 1,431 2,277 2,578 2,820
Operating Margin 12.51% 11.35% 13.85% 11.29% 8.48% 12.49% 13.41% 13.8%
Earnings before Tax (EBT) 1 1,580 1,454 1,630 1,501 1,198 1,909 2,371 2,667
Net income 1 1,198 1,084 1,254 1,154 943 1,482 1,825 2,060
Net margin 8.84% 7.42% 9.11% 7.93% 5.59% 8.13% 9.49% 10.08%
EPS 2 3.140 2.840 3.280 3.020 2.470 3.875 4.770 5.362
Free Cash Flow 1 962 252 1,706 450 349 898.6 1,475 1,810
FCF margin 7.1% 1.73% 12.4% 3.09% 2.07% 4.93% 7.67% 8.86%
FCF Conversion (EBITDA) 36.45% 8.6% 54.86% 16.78% 13.44% 26.35% 38.06% 43.52%
FCF Conversion (Net income) 80.3% 23.25% 136.04% 38.99% 37.01% 60.62% 80.84% 87.87%
Dividend per Share 2 1.800 1.800 2.200 2.400 2.400 2.515 2.840 2.971
Announcement Date 5/29/19 5/29/20 5/28/21 5/25/22 5/25/23 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: April 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 3,697 3,602 4,239 3,327 4,081 4,337 5,125 3,828 4,732 4,537 5,085 4,000 4,950 4,975 5,650
EBITDA 1 780 591 833 394 583 738 1,069 707 817 807 1,129 697 957 986 -
EBIT 1 533 340 570 132 316 463 784 427 542 525 773.2 408 668 697 -
Operating Margin 14.42% 9.44% 13.45% 3.97% 7.74% 10.68% 15.3% 11.15% 11.45% 11.57% 15.2% 10.2% 13.49% 14.01% -
Earnings before Tax (EBT) 1 503 300 534 78 160 273 689 305 442 392 678.5 321 586 622 749
Net income 1 383 229 415 60 122 216 546 238 344 305 529.2 250 457 485 -
Net margin 10.36% 6.36% 9.79% 1.8% 2.99% 4.98% 10.65% 6.22% 7.27% 6.72% 10.41% 6.25% 9.23% 9.75% -
EPS 2 1.000 0.6000 1.090 0.1600 0.3200 0.5600 1.430 0.6200 0.9000 0.8000 1.380 0.6500 1.190 1.260 1.520
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/25/21 2/24/22 5/25/22 8/25/22 11/24/22 2/24/23 5/25/23 8/24/23 11/30/23 2/29/24 - - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 439 1,632 774 1,532 2,442 3,020 2,626 2,055
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.1664 x 0.5568 x 0.2489 x 0.5712 x 0.9407 x 0.8857 x 0.6775 x 0.4942 x
Free Cash Flow 1 962 252 1,706 450 349 899 1,475 1,810
ROE (net income / shareholders' equity) 16.2% 14% 16% 14% 10% 15.5% 17.2% 17.8%
ROA (Net income/ Total Assets) 5.01% 4.13% 4.71% 4.51% 4.25% 4.99% 5.96% 6.54%
Assets 1 23,912 26,237 26,624 25,573 22,209 29,710 30,602 31,474
Book Value Per Share 2 20.40 21.20 21.50 23.30 25.50 26.80 29.30 31.90
Cash Flow per Share 2 4.250 2.650 6.680 4.860 5.140 7.600 8.900 9.800
Capex 1 659 762 845 1,408 1,564 1,541 1,415 1,308
Capex / Sales 4.86% 5.22% 6.14% 9.68% 9.27% 8.45% 7.36% 6.4%
Announcement Date 5/29/19 5/29/20 5/28/21 5/25/22 5/25/23 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Elekta AB

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
75.6 SEK
Average target price
83.42 SEK
Spread / Average Target
+10.34%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ELEKTA AB Stock Elekta AB
-8.16% 2.63B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
RESMED, INC. Stock ResMed, Inc.
+26.76% 32.03B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. EKTA B Stock
  4. Financials Elekta AB